CoChat

Maternal and Neonatal Morbidity for Women Who Would Be Added to the Diagnosis of GDM Using IADPSG Criteria: A Secondary Analysis of the Hyperglycemia and Adverse Pregnancy Outcome Study

Open access

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess the frequency of adverse outcomes for women who are diagnosed with gestational diabetes mellitus (GDM) by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria using data from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. RESEARCH DESIGN AND METHODS: This is a secondary analysis from the North American HAPO study centers. Glucose measurements from a 75-g oral glucose tolerance test were used to group participants into three nonoverlapping categories: GDM based on Carpenter-Coustan (CC) criteria (also GDM based on IADPSG criteria), GDM diagnosed based on IADPSG criteria but not CC criteria, and no GDM. Newborn outcomes included birth weight, cord C-peptide, and newborn percentage fat above the 90th percentile; maternal outcomes included primary cesarean delivery and preeclampsia. Outcome frequencies were compared using multiple logistic regression, adjusting for predefined covariates. RESULTS: Among 25,505 HAPO study participants, 6,159 blinded participants from North American centers were included. Of these, 81% had normal glucose testing, 4.2% had GDM based on CC criteria, and 14.3% had GDM based on IADPSG criteria but not CC criteria. Compared with women with no GDM, those diagnosed with GDM based on IADPSG criteria had adjusted odds ratios (95% CIs) for birth weight, cord C-peptide, and newborn percentage fat above the 90th percentile, as well as primary cesarean delivery and preeclampsia, of 1.87 (1.50–2.34), 2.00 (1.54–2.58), 1.73 (1.35–2.23), 1.31 (1.07–1.60), and 1.73 (1.32–2.27), respectively. CONCLUSIONS: Women diagnosed with GDM based on IADPSG criteria had higher adverse outcome frequencies compared with women with no GDM. These data underscore the need for research to assess the effect of treatment to improve outcomes in such women.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc16-1194

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 22 references

Research works printed but not linked: 2

  1. World Health Organization, 2013, Diagnostic Criteria and Classification of Hyperglyacemia First Detected in Pregnancy
  2. IDF Clinical Guidelines Task Force, 2009, Global Guidelines on Pregnancy and Diabetes

Cited by

Metadata

Authors
Waters, T. P., Dyer, A. R., Scholtens, D. M., Dooley, S. L., Herer, E., Lowe, L. P., Oats, J. J. N., Persson, B., Sacks, D. A., Metzger, B. E., & Catalano, P. M.
Affiliations
  • Loyola University Medical Center (US)
  • Northwestern University (US)
  • Sunnybrook Health Science Centre (CA)
  • The University of Melbourne (AU)
  • Karolinska Institutet (SE)
  • Kaiser Foundation Hospital (US)
  • MetroHealth (US)
Corresponding author
Waters, Thaddeus P.
Venue
Diabetes Care
Published
2016-09-15
Volume
39
Issue
12
Pages
2204-2210
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2481537205
Cited by
111
References
22
Citations by year
2026: 2 · 2025: 7 · 2024: 8 · 2023: 16 · 2022: 14 · 2021: 15 · 2020: 15 · 2019: 15 · 2018: 9 · 2017: 10
FWCI
14.64
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Child Health and Human Development (R-01-HD-34242)
  • National Research Resources Grants (M01-RR-00048, M01-RR-00080)
  • National Institute of Diabetes, Digestive, and Kidney Diseases Grants (R-01-34243)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and Neonatal Healthcare
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
gestational diabetes mellitus, IADPSG criteria, Carpenter and Coustan criteria, diagnostic thresholds, maternal morbidity, neonatal outcomes, birth weight, neonatal adiposity, cesarean section, preeclampsia
MeSH terms
Adult, Female, Glucose Tolerance Test, Humans, Hyperglycemia, Infant, Newborn, Infant, Newborn, Diseases, Morbidity, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Prognosis, Retrospective Studies, Diabetes, Gestational, Reproductive History

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.